In this regard, loss of dystroglycan during the EMT process and metastatic spread of prostate cancer, followed by re-expression of dystroglycan during mesenchymal to epithelial transition (MET) at a secondary site, mirrors findings with other cell adhesion molecules such as E-cadherin32. Here, DAG1 is linked to prostate cancer.